| Authors: |
O'Connell KA; Brigham & Women's/Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Thomas JL; Division of Dermatology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Weill Cornell Medical College, New York, New York, USA., Murad F; Brigham & Women's/Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Sonpavde GP; AdventHealth Cancer Institute, Orlando, Florida, USA., Mossanen M; Division of Urology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Clinton TN; Division of Urology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Ji-Xu A; Department of Dermatology, University of California, Davis, School of Medicine, Sacramento, California, USA., Spiess PE; Moffitt Cancer Center, Tampa, Florida, USA., Rossi AM; Division of Dermatology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Weill Cornell Medical College, New York, New York, USA., Schmults CD; Brigham & Women's/Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. |
